212 related articles for article (PubMed ID: 21156648)
1. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways.
Saydam O; Senol O; Würdinger T; Mizrak A; Ozdener GB; Stemmer-Rachamimov AO; Yi M; Stephens RM; Krichevsky AM; Saydam N; Brenner GJ; Breakefield XO
Cancer Res; 2011 Feb; 71(3):852-61. PubMed ID: 21156648
[TBL] [Abstract][Full Text] [Related]
2. miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors.
Erkan EP; Breakefield XO; Saydam O
Oncotarget; 2011 Mar; 2(3):265-70. PubMed ID: 21454924
[TBL] [Abstract][Full Text] [Related]
3. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway.
Liu Z; Liu Z; Zhang Y; Li Y; Liu B; Zhang K
Biochem Biophys Res Commun; 2017 Apr; 486(2):211-217. PubMed ID: 28189676
[TBL] [Abstract][Full Text] [Related]
4. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.
Licciulli S; Maksimoska J; Zhou C; Troutman S; Kota S; Liu Q; Duron S; Campbell D; Chernoff J; Field J; Marmorstein R; Kissil JL
J Biol Chem; 2013 Oct; 288(40):29105-14. PubMed ID: 23960073
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
6. PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation.
Wu DW; Wu TC; Chen CY; Lee H
Clin Cancer Res; 2016 Nov; 22(21):5370-5382. PubMed ID: 27178741
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.
Chua BT; Lim SJ; Tham SC; Poh WJ; Ullrich A
Mol Oncol; 2010 Aug; 4(4):323-34. PubMed ID: 20359967
[TBL] [Abstract][Full Text] [Related]
8. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma.
Ammoun S; Flaiz C; Ristic N; Schuldt J; Hanemann CO
Cancer Res; 2008 Jul; 68(13):5236-45. PubMed ID: 18593924
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
10. Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.
Yi C; Wilker EW; Yaffe MB; Stemmer-Rachamimov A; Kissil JL
Cancer Res; 2008 Oct; 68(19):7932-7. PubMed ID: 18829550
[TBL] [Abstract][Full Text] [Related]
11. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R
Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278
[TBL] [Abstract][Full Text] [Related]
12. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
Ma J; Li T; Yuan H; Han X; Shui S; Guo D; Yan L
J Cell Biochem; 2018 Mar; 119(3):2617-2626. PubMed ID: 29023945
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs impair MET-mediated invasive growth.
Migliore C; Petrelli A; Ghiso E; Corso S; Capparuccia L; Eramo A; Comoglio PM; Giordano S
Cancer Res; 2008 Dec; 68(24):10128-36. PubMed ID: 19074879
[TBL] [Abstract][Full Text] [Related]
15. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
Deng M; Tang H; Zhou Y; Zhou M; Xiong W; Zheng Y; Ye Q; Zeng X; Liao Q; Guo X; Li X; Ma J; Li G
J Cell Sci; 2011 Sep; 124(Pt 17):2997-3005. PubMed ID: 21878506
[TBL] [Abstract][Full Text] [Related]
16. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
Mahajan NP; Whang YE; Mohler JL; Earp HS
Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
[TBL] [Abstract][Full Text] [Related]
17. microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes.
Song N; Ma X; Li H; Zhang Y; Wang X; Zhou P; Zhang X
Urol Oncol; 2015 May; 33(5):205.e1-11. PubMed ID: 25758424
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.
Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS
Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162
[TBL] [Abstract][Full Text] [Related]
19. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
20. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.
Xu C; Zeng Q; Xu W; Jiao L; Chen Y; Zhang Z; Wu C; Jin T; Pan A; Wei R; Yang B; Sun Y
Mol Cancer Ther; 2013 Feb; 12(2):207-19. PubMed ID: 23270926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
